BIOPSY SCIENCES, LLC. MAXI-CELL BIOPSY NEEDLES— 510(k) K021847

Substantially Equivalent

Biopsy Sciences, LLC

FDA 510(k) clearance K021847 for BIOPSY SCIENCES, LLC. MAXI-CELL BIOPSY NEEDLES, Substantially Equivalent on 2002-09-03. Applicant: Biopsy Sciences, LLC.

Clearance details

Applicant: Biopsy Sciences, LLC
Product code: Code FCG
Advisory panel: Gastroenterology, Urology
Date received: 2002-06-05
Decision date: 2002-09-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Yorba Linda, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code FCG

product code FCG

Death: 13
Injury: 576
Malfunction: 1,966
Total: 2,555

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.